Market Share-Based Rebates Are Not Rx Switch Deals, Manufacturers Argue
Executive Summary
Drug rebates based on market share and payments to PBMs to disseminate product information are not switching arrangements, a group of 19 manufacturers maintain in comments on the HHS Inspector General's draft compliance guidance
You may also be interested in...
PhRMA Rx Marketing Code-Based Safe Harbor Should Be Considered By IG
The HHS Inspector General should consider establishing a "safe harbor" provision based on the Pharmaceutical Research & Manufacturers of America's marketing code, the industry association recommended
PhRMA Rx Marketing Code-Based Safe Harbor Should Be Considered By IG
The HHS Inspector General should consider establishing a "safe harbor" provision based on the Pharmaceutical Research & Manufacturers of America's marketing code, the industry association recommended
AWP Reform Plan For Medicare-Covered Drugs Could Open Program To PBMs
A proposed competitive bidding program for Medicare Part B-covered drugs could serve as a gateway for PBMs to become involved in managing Medicare drugs